00:00President Trump says imported generic medicines could face tariffs as high as 100% beginning in
00:062028, with rates potentially doubling the following year, in a bid to bring pharmaceutical
00:11manufacturing back to the United States. The delayed timeline is designed to give drug makers
00:17time to build domestic production before the levies take effect. Supporters say the plan
00:22strengthens supply chain security, while critics warn it could eventually drive up health care
00:26costs. The proposal marks one of the administration's most aggressive trade moves aimed at reshaping
00:32the pharmaceutical industry.
Comments